查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1561539

2024-2032 年按应用、服务、最终用途和地区分類的计算生物学市场报告

Computational Biology Market Report by Application, Services, End Use, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2023年全球计算生物学市场规模达58IMARC Group美元。

计算生物学，也称为生物资讯学，是一门跨学科的科学分支，它利用数学、统计学和电脑科学来理解和建模生命的结构和过程。它涉及生物学的各个方面，如遗传学、进化论、细胞生物学和生物化学。该过程使用包括演算法在内的计算技术来表示和模拟生物系统并解释大规模的实验资料。计算生物学还透过根据氨基酸序列、核苷酸和大分子结构创建生物资讯资料库来帮助了解疾病和细胞功能的治疗。如今，计算生物学已成为生物研究计画的重要组成部分，包括人类基因组计画、蛋白质资料和基因组资料库。

计算生物学市场趋势：

全球计算生物学市场主要受到药物基因组学领域临床研究数量不断增加的推动。这有助于增加对患者群体的多样化生物组成、生物途径以及支撑它们的基因组的了解。因此，对计算生物学解决方案的需求很高，因为它们有助于减少药物发现和各种其他科学实验所需的总时间。该过程还有助于模拟高级药物相互作用的工具的可视化。除此之外，表观基因体学、蛋白质体学和宏基因体学中计算生物学对蛋白质结构和交互作用的需求不断增长，也推动了市场的成长。此外，药物开发和疾病建模方面的各种技术进步，以及私人和政府组织对研发（R＆D）活动的​​投资增加，预计也将在不久的将来为市场提供积极的推动力。

本报告回答的关键问题

  • 2023 年全球计算生物学市场规模有多大？ 2024-2032年全球计算生物学市场的预期成长率是多少？
  • 推动全球计算生物学市场的关键因素是什么？
  • COVID-19 对全球计算生物学市场有何影响？
  • 基于应用的全球计算生物学市场的细分是什么？
  • 基于服务的全球计算生物学市场的细分是什么？
  • 根据最终用途，全球计算生物学市场的细分是什么？
  • 全球计算生物学市场的关键区域有哪些？
  • 谁是全球计算生物学市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球计算生物学市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按应用

  • 细胞和生物模拟
    • 市场趋势
    • 关键环节
      • 计算基因组学
      • 计算蛋白质体学
      • 药物基因组学
      • 其他的
    • 市场预测
  • 药物发现与疾病建模
    • 市场趋势
    • 关键环节
      • 目标识别
      • 目标验证
      • 潜在客户发现
      • 潜在客户优化
    • 市场预测
  • 临床前药物开发
    • 市场趋势
    • 关键环节
      • 药物动力学
      • 药效学
    • 市场预测
  • 临床试验
    • 市场趋势
    • 关键环节
      • 第一阶段
      • 第二阶段
      • 第三阶段
    • 市场预测
  • 人体模拟软体
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：按服务

  • 内部
    • 市场趋势
    • 市场预测
  • 合约
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：最终用途别

  • 学者
    • 市场趋势
    • 市场预测
  • 医药行业
    • 市场趋势
    • 市场预测
  • 商业的
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Certara
    • Chemical Computing Group ULC
    • Compugen Ltd
    • Dassault Systemes
    • Genedata AG
    • Insilico Biotechnology AG
    • Instem plc
    • Nimbus Therapeutics LLC
    • Schrodinger Inc.
    • Simulations Plus Inc.
Product Code: SR112024A4495

The global computational biology market size reached US$ 5.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 28.3 Billion by 2032, exhibiting a growth rate (CAGR) of 18.8% during 2024-2032.

Computational biology, also known as bioinformatics, is the interdisciplinary branch of science that uses math, statistics and computer science for understanding and modeling the structures and processes of life. It involves various aspects of biology, such as genetics, evolution, cell biology, and biochemistry. The process uses computational techniques, including algorithms, to represent and simulate biological systems and interpret experimental data on a large scale. Computational biology also helps understand the treatment for diseases and cellular function by creating a database of biological information from amino-acid sequences, nucleotides, and macromolecular structures. Nowadays, computational biology has become an essential part of biological research projects, including the human genome project, protein data banks and genomic databases.

Computational Biology Market Trends:

The global computational biology market is primarily driven by the rising number of clinical studies in the field of pharmacogenomics. This has helped increase the understanding of the diverse biological makeup of the patient population, biological pathways, and the genomes underpinning them. As a result, there is a high demand for computational biology solutions, as they help reduce the overall time needed for drug discovery and various other scientific experiments. The process also aids the visualization of tools to simulate advanced drug-drug interactions. In addition to this, the growing demand for computational biology in epi-genomics, proteomics, and meta-genomics to undertint protein structures and interactions is also propelling the market growth. Furthermore, various technological advancements in drug development and disease modeling, along with increasing investments by private and government organizations in research and development (R&D) activities, are also anticipated to provide a positive thrust to the market in the near future.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global computational biology market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on application, services and end use.

Breakup by Application:

  • Cellular and Biological Simulation
    • Computational Genomics
    • Computational Proteomics
    • Pharmacogenomics
    • Others
  • Drug Discovery and Disease Modelling
    • Target Identification
    • Target Validation
    • Lead Discovery
    • Lead Optimization
  • Preclinical Drug Development
    • Pharmacokinetics
    • Pharmacodynamics
  • Clinical Trials
    • Phase I
    • Phase II
    • Phase III
  • Human Body Simulation Software

Breakup by Services:

  • In-house
  • Contract

Breakup by End Use:

  • Academics
  • Pharmaceutical Industry
  • Commercial

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Certara, Chemical Computing Group ULC, Compugen Ltd, Dassault Systemes, Genedata AG, Insilico Biotechnology AG, Instem plc, Nimbus Therapeutics LLC, Schrodinger Inc. and Simulations Plus Inc

Key Questions Answered in This Report

  • 1. What was the size of the global computational biology market in 2023?
  • 2. What is the expected growth rate of the global computational biology market during 2024-2032?
  • 3. What are the key factors driving the global computational biology market?
  • 4. What has been the impact of COVID-19 on the global computational biology market?
  • 5. What is the breakup of the global computational biology market based on the application?
  • 6. What is the breakup of the global computational biology market based on the services?
  • 7. What is the breakup of the global computational biology market based on the end use?
  • 8. What are the key regions in the global computational biology market?
  • 9. Who are the key players/companies in the global computational biology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Computational Biology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Application

  • 6.1 Cellular and Biological Simulation
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Computational Genomics
      • 6.1.2.2 Computational Proteomics
      • 6.1.2.3 Pharmacogenomics
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Drug Discovery and Disease Modelling
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Target Identification
      • 6.2.2.2 Target Validation
      • 6.2.2.3 Lead Discovery
      • 6.2.2.4 Lead Optimization
    • 6.2.3 Market Forecast
  • 6.3 Preclinical Drug Development
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Pharmacokinetics
      • 6.3.2.2 Pharmacodynamics
    • 6.3.3 Market Forecast
  • 6.4 Clinical Trials
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Phase I
      • 6.4.2.2 Phase II
      • 6.4.2.3 Phase III
    • 6.4.3 Market Forecast
  • 6.5 Human Body Simulation Software
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Services

  • 7.1 In-house
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Contract
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Academics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical Industry
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Commercial
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Certara
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 Chemical Computing Group ULC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Compugen Ltd
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Dassault Systemes
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Genedata AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Insilico Biotechnology AG
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Instem plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Nimbus Therapeutics LLC
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Schrodinger Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
    • 14.3.10 Simulations Plus Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials

List of Figures

  • Figure 1: Global: Computational Biology Market: Major Drivers and Challenges
  • Figure 2: Global: Computational Biology Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Computational Biology Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Computational Biology Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Computational Biology Market: Breakup by Services (in %), 2023
  • Figure 6: Global: Computational Biology Market: Breakup by End Use (in %), 2023
  • Figure 7: Global: Computational Biology Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Computational Biology (Cellular and Biological Simulation) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Computational Biology (Cellular and Biological Simulation) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Computational Biology (Drug Discovery and Disease Modelling) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Computational Biology (Drug Discovery and Disease Modelling) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Computational Biology (Preclinical Drug Development) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Computational Biology (Preclinical Drug Development) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Computational Biology (Clinical Trials) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Computational Biology (Clinical Trials) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Computational Biology (Human Body Simulation Software) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Computational Biology (Human Body Simulation Software) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Computational Biology (In-house) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Computational Biology (In-house) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Computational Biology (Contract) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Computational Biology (Contract) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Computational Biology (Academics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Computational Biology (Academics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Computational Biology (Pharmaceutical Industry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Computational Biology (Pharmaceutical Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Computational Biology (Commercial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Computational Biology (Commercial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Computational Biology Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Computational Biology Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Computational Biology Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Computational Biology Industry: SWOT Analysis
  • Figure 78: Global: Computational Biology Industry: Value Chain Analysis
  • Figure 79: Global: Computational Biology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Computational Biology Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Computational Biology Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 3: Global: Computational Biology Market Forecast: Breakup by Services (in Million US$), 2024-2032
  • Table 4: Global: Computational Biology Market Forecast: Breakup by End Use (in Million US$), 2024-2032
  • Table 5: Global: Computational Biology Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Computational Biology Market: Competitive Structure
  • Table 7: Global: Computational Biology Market: Key Players